Skip to main content
Premium Trial:

Request an Annual Quote

German Firms Collaborate on Sepsis MDx Test

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – German firms SIRS-Lab and Analytik Jena today announced a collaboration focused on sepsis diagnostics.

Under the deal, AJ Innuscreen, a subsidiary of Analytik Jena, will provide SIRS-Lab a platform for the automated isolation of nucleic acids and associated reagents. The products from Analytik Jena are tailored for the fully automated extraction of DNA in whole blood samples. A clinical study is underway to validate a PCR-based test being developed, which "should create the conditions to start marketing our sepsis diagnostics very soon," said Barbara Staehelin, CEO of SIRS-Lab, in a statement.

Axel Kunz, manager of corporate communications for SIRS-lab added that the goal is to get a CE-IVD mark for the test.

Financial terms of the deal were not disclosed.

Both Analytik-Jena and SIRS-Lab are based in Jena, Germany. Analytik-Jena provides systems for analytic measurements. SIRS-Lab is a molecular diagnostics firm focused on sepsis and other life-threatening infections.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.